Merck KGaA is in the investment-grade market Tuesday, a day after holding investor calls, to help fund its $3.9 billion ...

Germany's Merck KGaA on Thursday raised its full-year operating earnings guidance, excluding the effect of harsh foreign ...

German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.

The group lifted its full-year guidance for growth in underlying earnings, due to better prospects for its life-sciences and ...

Net profit rose in the second quarter compared to the same period of the previous year for German science and technology ...

XTRA:MRK 1 Year Share Price vs Fair Value Explore Merck KGaA's Fair Values from the Community and select yours ...

FRANKFURT, March 7 (Reuters) - Merck KGaA (MRCG.DE) forecast a return to modest operating earnings growth this year but only when adjusted for currency headwinds, citing a gradual recovery in ...

Aside from ongoing debt servicing requirements, Merck KGaA has few demands on its free cash flow (EUR 2 billion in 2023) other than its common stock dividend (EUR 0.3 billion in 2023) and ongoing ...

Aside from ongoing debt servicing requirements, Merck KGaA has few demands on its free cash flow (EUR 3 billion in 2022) other than its common stock dividend (EUR 0.2 billion in 2022) and ongoing ...

Merck KGaA is the world's largest still-operating pharma and healthcare company, with a 300+ year history. It has absolutely stellar fundamentals, and what risks do exist are well-covered by the ...

Merck KGaA’s forecast caveat came as the company tallied 5.2 billion euros ($5.41 billion) in first-quarter revenue, signaling a 12.2% increase over the same period in 2021.

Germany’s Merck KGaA said Thursday that it expects a challenging 2023, with adjusted earnings forecast to be stable or decline slightly and a hit from foreign-exchange rates, as it reported a ...